Aspect Partners
DXCM icon

Aspect Partners’s DexCom DXCM Stock Holding History

Aspect Partners’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$2.59K Buy
30
+14
+88% +$1.16K ﹤0.01% 495
2026
Q2 		$1.08K Buy
16
+5
+45% +$333 ﹤0.01% 569
2026
Q1 		$691 Hold
11
– – ﹤0.01% 633
2025
Q4 		$730 Buy
+11
New +$711 ﹤0.01% 654
2025
Q3 		– Sell
-3
Closed -$262 – 714
2025
Q2 		$262 Hold
3
– – ﹤0.01% 591
2025
Q1 		$205 Hold
3
– – ﹤0.01% 597
2024
Q4 		$233 Buy
+3
New +$222 ﹤0.01% 583
2024
Q3 		– Sell
-2
Closed -$227 – 564
2024
Q2 		$227 Buy
+2
New +$253 ﹤0.01% 554

Other funds holding DXCM

Chicago Capital
Chicago Capital Chicago, Illinois $4.32B AUM 31.14% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return
Provident Investment Management
Provident Investment Management Novi, Michigan $999M AUM 19.45% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return
Fisher Funds Management
Fisher Funds Management Auckland, New Zealand $3.44B AUM 17.27% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Beacon Investment Advisory Services
Beacon Investment Advisory Services Morristown, New Jersey $2.66B AUM 29.77% 1-Year Est. Return
Gradient Investments
Gradient Investments Arden Hills, Minnesota $7B AUM 14.85% 1-Year Est. Return
Isthmus Partners
Isthmus Partners Madison, Wisconsin $1.04B AUM 19.97% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return

Aspect Partners's DXCM Position: Q3 2026 in Review

Aspect Partners increased its DexCom (DXCM) stake by 88% in Q3 2026, buying an estimated $1.16K and bringing the position to 30 shares worth $2.59K. The position accounts for ﹤0.01% of the portfolio, ranked #495.

Aspect Partners first reported a position in DXCM in Q2 2024 and has held it in 8 quarters since. 230 funds tracked by Wall St. Rank hold DXCM as of Q3 2026.

  • Aspect Partners held 30 shares of DexCom worth $2.59K as of Q3 2026.
  • Aspect Partners bought 14 DexCom shares in Q3 2026, an estimated $1.16K.
  • DexCom made up ﹤0.01% of Aspect Partners's portfolio in Q3 2026, its #495 holding.
  • Aspect Partners first reported a position in DexCom in Q2 2024 and has held it in 8 quarters since.
  • 230 funds tracked by Wall St. Rank held DexCom as of Q3 2026.

Based on Aspect Partners's 13F filing for Q3 2026, filed 20 Oct 2026.